• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Bristol-Myers Squibb

Bristol-Myers Squibb

VY® T. Rowe Price Equity Income S IRPSX 3 Star

Last Price$14.30Day Change (%)0.35%
Open Price$14.30Day Change ($)0.05
Day Range14.30–14.3052-Week Range11.83–14.43

As of Fri 12/09/2016 | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Sepsis - Pipeline Review, H2 2016 - Key Vendors are Adrenomed AG, Batu Biologics & Bristol-Myers Squibb Company - Research and Markets

    Sepsis - Pipeline Review, H2 2016 - Key Vendors are Adrenomed AG, Batu Biologics & Bristol-Myers Squibb Company - Research and Markets

  2. AstraZeneca Says FDA Will Review Application for Bladder Cancer Drug

    AstraZeneca Says FDA Will Review Application for Bladder Cancer Drug

  3. Drugmakers Find Competition Doesn't Keep a Lid on Prices

    Drugmakers Find Competition Doesn't Keep a Lid on Prices

  4. Global Hepatitis Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020 - Research and Markets

    Global Hepatitis Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020 - Research and Markets

  5. The Corporate Reputation of Pharma 2015 - The Perspective of 110 Patient Groups with an Interest in Skin Conditions - Research and Markets

    The Corporate Reputation of Pharma 2015 - The Perspective of 110 Patient Groups with an Interest in Skin Conditions - Research and Markets

  6. Governor Martin O’Malley, Congressman Mick Mulvaney, Congressman Glenn Nye, General Stanley McChrystal Headline FiscalNote ReInvent Influence Summit

    Governor Martin O’Malley, Congressman Mick Mulvaney, Congressman Glenn Nye, General Stanley McChrystal Headline FiscalNote ReInvent Influence Summit

  7. Global Hybrid Operating Suites Market Analysis and Trends - Device & Application - Forecast to 2025 - Research and Markets

    Global Hybrid Operating Suites Market Analysis and Trends - Device & Application - Forecast to 2025 - Research and Markets

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.